Table 1.
Cell Type | Effective Concentration | Effects | Reference |
---|---|---|---|
HUVEC | 10–100 µM | eNOS↑; NO↑ | [48] |
EA.hy 926 | 10–100 µM | eNOS (via SIRT1/FOXO)↑; NO↑ | [14,48] |
HCAEC | 1–100 µM | eNOS (via SIRT1)↑ | [13] |
HUVEC | 0.1 µM | eNOS↑; VEGF↑; ET-1↓ | [33] |
BAEC, HUVEC | 1–100 nM | p-eNOS↑ (via ERα & Erk1/2) | [24] |
HUVEC | 1–100 µM | p-eNOS↑ (via AMPK) | [54] |
STA | 50 µM | p-eNOS↑ (via AMPK) | [55] |
RAEC | 100 µM | Ac-eNOS↓ | [56] |
Ac-eNOS; acetylated eNOS; BACE, bovine aortic endothelial cells; HCAEC, human coronary arterial endothelial cells; HUVEC, human umbilical vein endothelial cells; p-eNOS, phosphorylation of eNOS at serine 1177; STA, superior thyroid artery; RAEC, rat aortic endothelial cells; VEGF, vascular endothelial growth factor.